Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Health and Human Services Food and Drug Administration [Docket Nos. 00M-0811, 00M-1215, 00M-1216, 00M-0915, 99M-4619, 00M-0901, 99M-4763, 00M-0424, 00M-1073, 00M-0577, 00M-0579, 00M-0599, 00M-0445, 00M-0580, 00M-0578, 00M-0810, 00M-0809, 00M-1212]
 AGENCY: Food and Drug Administration, HHS.
 ACTION: Notice.
 SUMMARY: The Food and Drug Administration (FDA) is publishing a list of premarket approval applications (PMA's) that have been approved. This list is intended to inform the public of the availability of safety and effectiveness summaries of approved PMA's through the Internet and the agency's Dockets Management Branch.
 ADDRESSES: Summaries of safety and effectiveness are available on the Internet at http://www.fda.gov/​cdrh/​pmapage.html. Copies of summaries of safety and effectiveness are also available by submitting a written request to the Dockets Management Branch (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. Please cite the appropriate docket number as listed in table 1 in the 
                        **SUPPLEMENTARY INFORMATION**
                         section of this document when submitting a written request.
 FOR FURTHER INFORMATION CONTACT: Kathy M. Poneleit, Center for Devices and Radiological Health (HFZ-402), Food and Drug Administration, 9200 Corporate Blvd., Rockville, MD 20850, 301-594-2186.


SUPPLEMENTARY INFORMATION: In the 
                    **Federal Register**
                     of January 30, 1998 (63 FR 4571), FDA published a final rule to revise §§ 814.44(d) and 814.45(d) (21 CFR 814.44(d) and 814.45(d)) to discontinue publication of individual PMA approvals and denials in the 
                    **Federal Register**
                    . Instead, revised §§ 814.44(d) and 814.45(d) state that FDA will notify the public of PMA approvals and denials by posting them on FDA's Internet home page at http://www.fda.gov; by placing the summaries of safety and effectiveness on the Internet and in FDA's Dockets Management Branch; and by publishing in the 
                    **Federal Register**
                     after each quarter a list of available safety and effectiveness summaries of approved PMA's and denials announced in that quarter. FDA believes that this procedure expedites public notification of these actions because announcements can be placed on the Internet more quickly than they can be published in the 
                    **Federal Register**
                    , and FDA believes that the Internet is accessible to more people than the 
                    **Federal Register**
                    . In accordance with section 515(d)(3) of the Federal Food, Drug, and Cosmetic Act (the act) (21 U.S.C. 360e(d)(3)), notification of an order approving, denying, or withdrawing approval of a PMA will continue to include a notice of opportunity to request review of the order under section 515(g) of the act. The 30-day period for requesting reconsideration of an FDA action under § 10.33(b) (21 CFR 10.33(b)) for notices announcing approval of a PMA begins on the day the notice is placed on the Internet. Section 10.33(b) provides that FDA may, for good cause, extend this 30-day period. Reconsideration of a denial or withdrawal of approval of a PMA may be sought only by the applicant; in these cases, the 30-day period will begin when the applicant is notified by FDA in writing of its decision. The following is a list of approved PMA's for which summaries of safety and effectiveness were placed on the Internet in accordance with the procedure explained previously from January 1, 2000, through March 31, 2000. There were no denial actions during this period. The list provides the manufacturer's name, the product's generic name or the trade name, and the approval date. **Table**
                         1.—
                        **List of Safety and Effectiveness Summaries for Approved PMA's Made Available January 1, 2000, through March 31, 2000**
PMA Number/Docket No.
Applicant
Trade Name
Approval DateP970005/00M-0811
Kremer Laser Eye Center
Kremer Exciber Laser System (Serial #KEA940202)
July 30, 1998P970055/00M-1215
Biotrin International, Ltd.
Biotrin Parvovirus IgM EIA (V619IMUS)
August 6, 1999P970054/00M-1216
Biotrin International, Ltd.
Biotrin Parvovirus IgG EIA (V519IGUS)
August 6, 1999P980049/00M-0915
ELA Medical, Inc.
Defender II Model 9201 Implantable Cardiovascular Defibrillator
September 15, 1999H990003/99M-4619
American Medical Systems
ActiconTM
                             Neosphincter
September 20, 1999( print page 36818)P850022(S9)/00M-0901
Biolectron Inc.
SpinalPak® Stimulator
September 24, 1999H990005/99M-4763
Nitinol Medical Technologies
CardioSEAL® Septal Occlusion System
September 28, 1999P930034(S12)/00M-0424
Summit Technology
SVS Apex Plus Excimer Laser Workstation w/the Emphasis Discs
October 21, 1999P910066(S11)/00M-1073
Orthologic Corp.
OrthologicTM
                             1000 Bone Growth Stimulator
December 17, 1999P990035/00M-0577
Sunlight Ultrasound Technologies, Ltd.
The SunlightTM
                             Omnisense Ultrasound Bone Sonometer
January 20, 2000P990066/00M-0579
GE Medical Systems
Senographe 2000D
January 28, 2000H990011/00M-0599
Nitinol Medical Technologies
CardioSEAL® Septal Occlusion System
February 1, 2000P980040/00M-0445
Allergan Inc.
Sensar Soft Acrylic UV-Light Absorbing Posterior Chamber Intraocular Lens
February 3, 2000P990016/00M-0580
McCue Corporation, Inc.
McCue CUBAClinical Ultraonic Bone Sonometry System w/CUBAplus+V4.1.0
February 15, 2000P940034(S8)/00M-0578
Gen-Probe Incorporated
Gen-Probe® AmplifiedTM
                             Mycobacterium Tuberculosis Direct (MTD) Test
February 15, 2000P900009(S6)/00M-0810
Smith & Nephew Inc.
Exogen 2000 or Sonic Accelerated Fracture Healing System
February 22, 2000P990023/00M-0809
Alcon Labs
Cellugel® Ophthalmic Viscosurgical Device
February 24, 2000P950019(S9)/00M-1212
United States Surgical Corp.
Ray Threaded Fusion Cage (TFC) w/Instrumentation
March 2, 2000
 Dated: May 23, 2000. Linda S. Kahan, Deputy Director for Regulations Policy, Center for Devices and Radiological Health.


[FR Doc. 00-14702 Filed 6-9-00; 8:45 am] BILLING CODE 4160-01-F